Cutler Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,800
| Closed | -$183K | – | 2167 |
|
|
2023
Q2 | $183K | Buy |
1,800
+800
| +80% | +$81.3K | 0.03% | 352 |
|
|
2023
Q1 | $90K | Sell |
1,000
-5,000
| -83% | -$450K | 0.01% | 508 |
|
|
2022
Q4 | $227K | Buy |
6,000
+1,946
| +48% | +$73.6K | 0.02% | 414 |
|
|
2022
Q3 | $101K | Sell |
4,054
-732
| -15% | -$18.2K | 0.01% | 662 |
|
|
2022
Q2 | $145K | Sell |
4,786
-5,216
| -52% | -$158K | 0.01% | 566 |
|
|
2022
Q1 | $327K | Buy |
10,002
+5,170
| +107% | +$169K | 0.02% | 450 |
|
|
2021
Q4 | $127K | Buy |
4,832
+3,532
| +272% | +$92.8K | 0.01% | 850 |
|
|
2021
Q3 | $130K | Buy |
1,300
+946
| +267% | +$94.6K | 0.01% | 857 |
|
|
2021
Q2 | $50K | Sell |
354
-506
| -59% | -$71.5K | ﹤0.01% | 1234 |
|
|
2021
Q1 | $85K | Buy |
+860
| New | +$85K | ﹤0.01% | 965 |
|
|
2020
Q4 | – | Sell |
-3,400
| Closed | -$331K | – | 2519 |
|
|
2020
Q3 | $331K | Buy |
3,400
+3,240
| +2,025% | +$315K | 0.02% | 376 |
|
|
2020
Q2 | $24K | Buy |
+160
| New | +$24K | ﹤0.01% | 1045 |
|
|
2020
Q1 | – | Sell |
-61
| Closed | -$12K | – | 2213 |
|
|
2019
Q4 | $12K | Buy |
+61
| New | +$12K | ﹤0.01% | 1208 |
|
|
2019
Q3 | – | Sell |
-3,825
| Closed | -$360K | – | 2297 |
|
|
2019
Q2 | $360K | Buy |
3,825
+200
| +6% | +$18.8K | 0.03% | 318 |
|
|
2019
Q1 | $309K | Buy |
3,625
+2,825
| +353% | +$241K | 0.03% | 349 |
|
|
2018
Q4 | $44K | Buy |
+800
| New | +$44K | ﹤0.01% | 878 |
|
|
2018
Q3 | – | Sell |
-500
| Closed | -$17K | – | 2319 |
|
|
2018
Q2 | $17K | Hold |
500
| – | – | ﹤0.01% | 1178 |
|
|
2018
Q1 | $10K | Buy |
500
+100
| +25% | +$2K | ﹤0.01% | 1401 |
|
|
2017
Q4 | $11K | Buy |
+400
| New | +$11K | ﹤0.01% | 1590 |
|